SBIR/STTR Research Award

Topical Silver Sulfadiazine Formulations with Improved Efficacy and Toxicity Prof

Award identifier 0cac87a3e3030acc82b4ed2c86d5dfd83e017182386f7ff660080b009a42b459Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$270,598

Program and phase

SBIR · Phase I

Award year

2014

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
Novion Technologies
Proposal award date
2014-09-25
Contract end date
2016-09-22
UEI
WQWMDUXKY7K3
Solicitation number
PA14-077
Topic code
300

Research abstract

DESCRIPTION provided by applicant Silver Sulfadiazine SSD is the most widely used topical antimicrobial agent in the world and while effective against a wide variety of pathogens i has been shown to delay wound healing Formulation of SSD into creams and gels with the inclusion of a naturally occurring component additive has been shown to significantly lower the toxicity of the formulation improve the solubility of SSD and improve the efficacy of the drug against several leading burn pathogens The major specific aims of the proposed research involve the preparation andamp formulation processing of the SSD in cream and gel formulations with varying concentrations of the naturally occurring additive determination of antimicrobial efficacy cyto compatability and evaluation in an infected burn wound model in the rat The primary objectives of the proposed therapy are resolution of infection improvement of healing and reduction in overall inflammation This innovative and rational approach to an improved topical antimicrobial therapy is founded on the basis of several different studies that have revealed promising bioapplicable attributes of this improved and commonly applied therapy The end goal of this project is to enable the next phase of development of one or more of these novel microbicidal formulations that will be targeted for the treatment of burn wounds PUBLIC HEALTH RELEVANCE Infection is the most common and most serious complication of a major burn injury Despite improvements in burn wound management and antimicrobial therapy technologies sepsis related to the burn accounts for of deaths in burn patients today Other complicating issues that hamper efficient healing include cellular oxidative stress topical agent toxicity and ease of patient treatment Antimicrobial creams and gels using a well known and controversial antimicrobial compound formulated to minimize toxicity so as to not delay healing provide good efficacy against relevant burn pathogens maintain soothing and hydrating properties remain cost effective and easy to clean from the patient is proposed as a solution to the aforementioned complications of burn injury

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

2 SBIR/STTR records share this UEI (2013–2014). Reported award amounts total $619,817. Reported amounts are not federal obligations.

Phases: Phase I

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.